Xtant Medical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xtant Medical and other ETFs, options, and stocks.About XTNT
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoSTX, Certex Spinal Fixation System, Axle Interspinous Fusion System, and Calix.
CEOSean E. Browne
CEOSean E. Browne
Employees232
Employees232
HeadquartersBelgrade, Montana
HeadquartersBelgrade, Montana
Founded2006
Founded2006
Employees232
Employees232
XTNT Key Statistics
Market cap111.89M
Market cap111.89M
Price-Earnings ratio72.06
Price-Earnings ratio72.06
Dividend yield—
Dividend yield—
Average volume225.09K
Average volume225.09K
High today$0.8154
High today$0.8154
Low today$0.75
Low today$0.75
Open price$0.7576
Open price$0.7576
Volume563.73K
Volume563.73K
52 Week high$0.95
52 Week high$0.95
52 Week low$0.3401
52 Week low$0.3401
Stock Snapshot
Xtant Medical(XTNT) stock is priced at $0.80, giving the company a market capitalization of 111.89M. It carries a P/E multiple of 72.06.
On 2025-12-17, Xtant Medical(XTNT) stock moved within a range of $0.75 to $0.82. With shares now at $0.80, the stock is trading +6.6% above its intraday low and -2.0% below the session's peak.
Trading activity shows a volume of 563.73K, compared to an average daily volume of 225.09K.
The stock's 52-week range extends from a low of $0.34 to a high of $0.95.
The stock's 52-week range extends from a low of $0.34 to a high of $0.95.
XTNT News
TipRanks 7d
Xtant Medical announces commercial launch of StrataXtant Medical (XTNT) Holdings announced the commercial launch of its next-generation innovative synthetic bone graft in the nanOss line, Strata. Strata is avail...
People also own
Based on the portfolios of people who own XTNT. This list is generated using Robinhood data, and it’s not a recommendation.